SciShow: Who Named the New COVID-19 Drug Bamlanivimab? | An Interview with Daniel Skovronsky

Teacher or professor: SciShow
Subject: Science
Content of the Lesson: Earlier this month, we talked with Daniel Skovronksy, the Chief Scientific Officer of Eli Lilly, about their colorfully-named COVID-19 treatments. We also discussed the challenges of mass-producing antibodies and how medicine might change going forward. Hosted by: Hank Green & Alexis Dahl SciShow has a spinoff podcast! It's called SciShow Tangents. Check it out at http://www.scishowtangents.org ---------- Support SciShow by becoming a patron on Patreon: https://www.patreon.com/scishow ---------- Huge thanks go to the following Patreon supporters for helping us keep SciShow free for everyone forever: Marwan Hassoun, Jb Taishoff, Bd_Tmprd, Harrison Mills, Jeffrey Mckishen, James Knight, Christoph Schwanke, Jacob, Matt Curls, Sam Buck, Christopher R Boucher, Eric Jensen, Lehel Kovacs, Adam Brainard, Greg, Ash, Sam Lutfi, Piya Shedden, KatieMarie Magnone, Scott Satovsky Jr, charles george, Alex Hackman, Chris Peters, Kevin Bealer ---------- Looking for SciShow elsewhere on the internet? Facebook: http://www.facebook.com/scishow Twitter: http://www.twitter.com/scishow Tumblr: http://scishow.tumblr.com Instagram: http://instagram.com/thescishow ---------- Sources: https://www.istockphoto.com/vector/infographic-depicting-the-external-and-internal-coronavirus-structure-gm1202867079-345507611 https://www.istockphoto.com/vector/concepts-of-monoclonal-antibody-for-coronavirus-treatment-gm1279978172-378415156


Click here to view video on YouTube.